NONA
AMED

Ninety One North America’s Amedisys AMED Stock Holding History

Ninety One North America’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-15,822
Closed -$2.36M – 110
2021
Q3 		$2.36M Hold
15,822
– – 0.11% 91
2021
Q2 		$3.88M Hold
15,822
– – 0.18% 79
2021
Q1 		$4.19M Buy
15,822
+935
+6% +$264K 0.24% 73
2020
Q4 		$4.37M Hold
14,887
– – 0.27% 69
2020
Q3 		$3.52M Sell
14,887
-140
-0.9% -$31.8K 0.39% 64
2020
Q2 		$2.98M Sell
15,027
-45,988
-75% -$8.58M 0.31% 61
2020
Q1 		$11.2M Buy
+61,015
New +$10.9M 0.93% 39

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

Ninety One North America's AMED Position: Q4 2021 in Review

Ninety One North America sold out of Amedisys (AMED) in Q4 2021, closing a stake of 15,822 shares — an estimated $2.36M sold.

Ninety One North America first reported a position in AMED in Q1 2020 and held it in 7 quarters. The position peaked at $11.2M in Q1 2020. 325 funds tracked by Wall St. Rank hold AMED as of Q4 2021.

  • Ninety One North America reported no remaining Amedisys position as of Q4 2021 after selling out during the quarter.
  • Ninety One North America sold 15,822 Amedisys shares in Q4 2021, an estimated $2.36M.
  • Ninety One North America first reported a position in Amedisys in Q1 2020 and held it in 7 quarters.
  • Ninety One North America's Amedisys position peaked at $11.2M in Q1 2020.
  • 325 funds tracked by Wall St. Rank held Amedisys as of Q4 2021.

Based on Ninety One North America's 13F filing for Q4 2021, filed 11 Feb 2022.